Oramed Pharmaceuticals (ORMP) Non-cash Items (2017 - 2025)

Oramed Pharmaceuticals has reported Non-cash Items for 9 years, with the latest figure at $5.0 million in Q4 2025.

• For the quarter ending Q4 2025, Non-cash Items rose 249.52% year-over-year to $5.0 million; the trailing twelve-month figure through Dec 2025 stood at $5.0 million (up 249.52% YoY), and the FY2025 full-year result was $5.0 million, up 249.52% from the prior year.
• Non-cash Items for Q4 2025 stood at $5.0 million, up from $1.4 million in the prior quarter.
• The five-year high for Non-cash Items was $5.0 million in Q4 2025, with the low at $47000.0 in Q4 2022.
• Historically, Non-cash Items has averaged $2.1 million across 5 years, with a median of $1.5 million in 2023.
• Annual changes were most pronounced in 2023 — Non-cash Items surged 3047.71% — and 2024, when it retreated 2.51%.
• Oramed Pharmaceuticals' Non-cash Items stood at $859447.0 in 2021, then slumped by 94.53% to $47000.0 in 2022, then surged by 3047.71% to $1.5 million in 2023, then decreased by 2.51% to $1.4 million in 2024, then surged by 249.52% to $5.0 million in 2025.
• The last three Non-cash Items figures came in at $5.0 million (Q4 2025), $1.4 million (Q4 2024), and $4.0 million (Q3 2024), per Business Quant data.